IPCALAB
IPCA Laboratories Limited
Pharmaceuticals
Share price
₹1,911
Market cap
₹48,460 Cr
1Y return
▲ 41%
A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.
Investors holding IPCA Laboratories Limited
9.54%
6.36%
4.64%
3.69%
1.94%
1.39%
1.14%
1.05%
Latest move
Axis Mutual FundIncreased
Axis Mutual Fund increased its stake in IPCA Laboratories from 1.83% to 1.94%, with its shareholding increasing from 4,633,704 to 4,911,931 shares. This additional 278,227 shares are valued at ₹49.97 crore, based on IPCA Laboratories' share price of ₹1796.30.
Sign in to read more
Whales made 8 more moves in IPCA Laboratories Limited
Sign in to see who is buying and selling.
Sign in to find out